AgeX Therapeutics (AGE) Institutional Ownership Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisEarningsHeadlinesOwnershipTrendsStock AnalysisEarningsHeadlinesOwnershipTrends Institutional Ownership Changes (13F Filings) for AgeX Therapeutics (NYSE:AGE)CurrentInstitutional OwnershipPercentage12.50%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$42.99KNumber ofInstitutional Sellers(last 12 months)0 Get AGE Insider Trade Alerts Want to know when executives and insiders are buying or selling AgeX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AGE Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here AgeX Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/1/2024Sigma Planning Corp286,425$110K0.0%+57.9%0.755% 11/6/2023Sigma Planning Corp181,385$123K0.0%+29.8%0.478% 4/20/2023Strategic Wealth Investment Group LLC600$57K0.0%-99.3%0.002% 2/14/2023Susquehanna International Group LLP52,381$29K0.0%N/A0.138% 1/24/2023Sigma Planning Corp134,977$74K0.0%+15.2%0.356% 10/21/2022Strategic Wealth Investment Group LLC82,010$46K0.0%-22.7%0.216% 8/11/2022Sigma Planning Corp116,650$67K0.0%+33.1%0.307% 1/21/2022Strategic Wealth Investment Group LLC112,251$122K0.0%+20.8%0.296% 10/28/2021Sigma Planning Corp88,200$83K0.0%+70.6%0.232% 8/17/2021Bridgeway Capital Management LLC244,770$379K0.0%-19.7%0.645% 8/13/2021Renaissance Technologies LLC75,059$116K0.0%-77.3%0.198% 8/13/2021Sigma Planning Corp51,700$80K0.0%+120.0%0.136% 5/18/2021Millennium Management LLC18,523$30K0.0%-82.3%0.049% 5/13/2021Renaissance Technologies LLC330,500$535K0.0%+212.7%0.871% 2/10/2021Renaissance Technologies LLC105,700$161K0.0%N/A0.280% 11/3/2020Strategic Wealth Designers57,325$46K0.0%+21.6%0.152% 10/23/2020Defender Capital LLC.35,597$29K0.0%-17.4%0.094% 10/20/2020Wedbush Securities Inc.67,927$55K0.0%N/A0.180% 8/31/2020Bridgeway Capital Management Inc.154,770$147K0.0%N/A0.411% 8/14/2020Bank of America Corp DE152,838$144K0.0%+8,238.1%0.406% 6/19/2020State Street Corp293,888$273K0.0%+11.8%0.780% 5/14/2020Wells Fargo & Company MN44,474$41K0.0%+630.2%0.118% (Data available from 1/1/2016 forward) AGE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AGE shares? During the previous two years, the following institutional investors and hedge funds held shares of AgeX Therapeutics shares: Sigma Planning Corp ($110K), and Strategic Wealth Investment Group LLC ($57K), Susquehanna International Group LLP ($29K).Learn more on AGE's institutional investors. What percentage of AgeX Therapeutics stock is owned by institutional investors? 12.50% of AgeX Therapeutics stock is owned by institutional investors. Learn more on AGE's institutional investor holdings. Which institutional investors have been buying AgeX Therapeutics stock? The following institutional investors have purchased AgeX Therapeutics stock in the last 24 months: Sigma Planning Corp ($193.50K), and Susquehanna International Group LLP ($52.38K). How much institutional buying is happening at AgeX Therapeutics? Institutional investors have bought a total of 245,883 shares in the last 24 months. This purchase volume represents approximately $77.64K in transactions. Which AgeX Therapeutics major shareholders have been selling company stock? The following institutional investors have sold AgeX Therapeutics stock in the last 24 months: Strategic Wealth Investment Group LLC ($109.87K). How much institutional selling is happening at AgeX Therapeutics? Institutional investors have sold a total of 109,868 shares in the last 24 months. This volume of shares sold represents approximately $44.00K in transactions. Related Companies: MSVB Major Shareholders LEXX Major Shareholders CARM Major Shareholders KZR Major Shareholders NXTC Major Shareholders YS Major Shareholders BTAI Major Shareholders MRKR Major Shareholders CALC Major Shareholders TPST Major Shareholders This page (NYSE:AGE) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AgeX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AgeX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.